BrightHeart’s AI software boosts prenatal heart defect detection by over 15%: study

Written By Amanda French

BrightHeart’s FDA-cleared AI software showed promise in improving the diagnostic rate of identifying congenital heart defects (CHDs) during prenatal ultrasounds, according to findings from two studies presented at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting. Brightheart's solution improved detection rates with a 15.3% increase in sensitivity and boosted efficiency, cutting reading time by 18% among specialists.

Amanda French
Previous

BrightHeart’s AI demonstrates promise in congenital heart defect detection
Next

AI assistance improves CHD detection on prenatal ultrasound